ArnettCDShiueC-YWolfAPFowlerJSLoganJWatanabeM, (1985) Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. J Neurochem44:835–844
2.
MintunMARaichleMEKilbournMRWootenGFWelchMJ, (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol15:217–227
3.
PerlmutterJSLarsonKBRaichleMEMarkhamJMintunMAKilbournMRWelchMJ, (1986) Strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab6:154–169
4.
PerlmutterJSRaichleME, (1987) (Response to) Concerning strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab7:253–255
5.
WagnerHNJrBurnsHDDannalsRF, (1983) Imaging dopamine receptors in the human brain by positron tomography. Science221:1264–1266
6.
WongDFWagnerHNJrDannalsRF, (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science226:1393–1396
7.
ZeebergBRBiceANWagnerHNJr., (1987) Concerning strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab7:252–253